Peripheral polyneuropathy, a rare complication of multiple myeloma, is generally associated with heavy-chain M-proteins and, in very rare instances, with free light-chain myeloma proteins. Here we describe a case of multiple myeloma and polyneuropathy with both monoclonal lgG and free lambda light chains in the blood. The patient also had free lambda light chains in the cerebrospinal fluid and urine.
Peripheral polyneuropathy is a rare complication of multiple myeloma, occurring in <1% of such patients (1,2)-It is generally associated with variable amounts of heavy-chain M-proteins or, in extremely rare instances, with a free lightchain protein (3, 4). Here we report a case of multiple myeloma and peripheral polyneuropathy with both monoclonal IgG lambda and free lambda light chains in the blood and free lambda light chains in the cerebrospinal fluid and urine.
Case Report
A 49-year-old woman was admitted because of a threemonth history of progressive weakness. Results of physical examination were unremarkable. Abnormal laboratory findings during the initial evaluation were: hemoglobin 80 g/L, serum creatunine 505 pmol/L, uric acid 0.61 mmol/L, calcium 3.0 mmol/L (reference intervals: 120-160; 60-130; 0.09-0.35; 2.26-2.76, respectively). Results of urinalysis were normal except for proteinuria of 2.5 g/24 h. Routine cellulose acetate zonal electrophoresis of the serum revealed two discrete fractions (11 and 10 g/L, respectively) with distinctly different mobilities in the gsmrnsi region and a decreased background staining, apparently ascribable to the suppression of normal immunoglobulin synthesis (Figure 1 Because her urinary volume was decreasing progressively and the renal-function tests showed deterioration, the patient was started on hemodialysis and chemotherapy (melphalan, oncovin, cyclophosphamide, and ultralan). Kidney biopsy revealed a marked thickening of the basal tubular membrane. Results of staining for amyloid were negative.
Four days after initiation of treatment, the patient developed plegia of both legs and hands. 
Discussion
This patient presented with multiple myeloma associated with a severe subacute inflammatory polyradiculoneuritis, including cranial polyneuritis (involving multiple cranial nerves and the four limbs), with a high protein content in the cerebrospinal fluid. The bone-marrow aspirate contained a large percentage of abnormal plasma cells. The monoclonal immunoglobulins in the serum and the free light chains in the urine were consistent with the clinical diagnosis of multiple myeloma. Myeloma with polyneuropathy is thought to be associated with osteoscierotic rather than osteolytic lesions. No bone involvement was seen in this patient.
Myeloma with polyneuropathy is generally associated with heavy-chain M-components, preponderantly of the IgG class and with lambda-type light chains (2). Only two cases of polyneuropathy with free light-chain myeloma (lambda type) have been documented (3,4). Our patient showed both monoclonal IgG lambda and free lambda light chains. The presence of free light chains in the serum may have been the result of overproduction in comparison with the rate of synthesis of heavy chains, but it may also represent the product of a second plasma-cell tumor (double gammopathy). No information on the cellular origin of these myeloma proteins is available in our patient. An excess of free light chains was reported in mice with experimental Ag. 1. Serum electrophoresisand immunofixation data SP, etectrophoreticpattern; G, lgG; K, kappa lightchain;x, lambda light chain. Anodeis at the bottom myeloma and polyneuropathy (5) . The rapid evolution in this case was apparently related to the large tumor mass secreting high amounts of myeloma proteins (21 g/L). The amount of light-chain protein excreted in urine and the presence of free lambda light chains in the spinal fluid also reflected the tumor cell mass.
